Rituximab is not a “magic drug” in post-transplant recurrence of nephrotic syndrome
Crossref DOI link: https://doi.org/10.1007/s00431-016-2747-1
Published Online: 2016-06-30
Published Print: 2016-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Grenda, Ryszard
Jarmużek, Wioletta
Rubik, Jacek
Piątosa, Barbara
Prokurat, Sylwester
License valid from 2016-06-30